Journal of Natural Products
Note
1670, 1598, 1517, 1440, 1371, 1292, 1182, 1105, 773, 640 cm−1;
HRESIMS m/z 603.3687 [M + H]+ (calcd for C38H51O6, 603.3686).
Crystal Data for 2. C38H50O6 (M = 602.78 g/mol): monoclinic,
space group P21 (no. 4), a = 14.5894(3) Å, b = 11.1597(3) Å, c =
20.4193(5) Å, β = 93.6280(10)°, V = 3317.87(14) Å3, Z = 4, T = 173.01
K, μ(Cu Kα) = 0.636 mm−1, Dcalc = 1.207 g/cm3, 22 097 reflections
measured (6.07° ≤ 2θ ≤ 136.87°), 11 551 unique (Rint = 0.0209, Rsigma
= 0.0294), which were used in all calculations. The final R1 was 0.0295
(I > 2σ(I)) and wR2 was 0.0826. Flack parameter = 0.06(4). Hooft =
0.06(4). Crystallographic data for 2 have been deposited at the
Cambridge Crystallographic Data Center (deposition number: CCDC
2032864).
Computational Details. The calculations of 1 were performed
using Gaussian 09. Conformational analysis was initially carried out
using Accelrys Discovery Studio 2.5 to generate conformers by Best,
then minimized by Smart Minimizer using the CHARMm molecular
mechanics force field. The minimized conformers were optimized at the
B3LYP/6-31G(d,g) level in the gas phase. Room-temperature
equilibrium populations were calculated according to the Boltzmann
distribution law. The ECD calculations were performed using TDDFT
at the B3LYP/6-31G(d,p) level in the gas phase. SpecDis 1.61 was used
to visualize the ECD spectra of 1 after a Boltzmann statistical weighting,
to generate the Gaussian curve, and for comparison with experimental
data.
EXPERIMENTAL SECTION
■
General Experimental Procedures. Optical rotations were
measured using an Autopol VI polarimeter. Ultraviolet absorption
spectra were recorded on a UV-2401 PC spectrophotometer. ECD
spectra were recorded on a Chirascan-plus spectrometer (Applied
Photophysics Ltd., Surrey, UK). IR spectra were recorded on a
PerkinElmer 577 spectrometer. NMR spectra were measured on Bruker
AV-400 and Bruker AV-600 spectrometers. Mass spectrometry was
performed on a SYNAPT G2-Si HDMS (Waters Corp., Manchester,
UK) with an electrospray ion source (Waters, Milford, MA, USA)
connected to a lock-mass apparatus, which performed real-time
calibration correction. Column chromatography was performed with
CHP20P MCI gel (75−150 μm, Mitsubishi Chemical Corporation,
Japan), silica gel (100−200 or 200−300 mesh, Qingdao Haiyang
Chemical Co., Ltd.), Sephadex LH-20 (GE Healthcare Bio-Sciences
AB, Sweden), and reversed-phase C18 silica gel (50 μm, YMC, Kyoto,
Japan). Precoated TLC sheets of silica gel 60 GF254 (Qingdao Haiyang
Chemical Co., Ltd.) were used.
Plant Material. The G. esculenta plants, including twigs and leaves,
were collected in Nujiang, Yunnan, People’s Republic of China, in
September 2014. The sample was identified by Dr. Hongmei Zhang,
Shanghai University of Traditional Chinese Medicine. A voucher
specimen (Herbarium No. 20140901) was deposited at the School of
Pharmacy, Shanghai University of Traditional Chinese Medicine.
Isolation of Compound 1. The dried and powdered plants of G.
esculenta, including twigs and leaves (23 kg), were extracted by refluxing
with 95% EtOH (4 × 200 L). The combined crude extracts were
evaporated, diluted with H2O, and extracted with petroleum ether and
EtOAc. The petroleum ether-soluble extract (350 g) was subjected to
passage over an MCI column eluted with H2O and 95% EtOH. The
95% EtOH-eluting fraction (249.3 g) was chromatographed by a silica
gel column using a gradient of petroleum ether/acetone (100:0 to
50:50, v/v) to afford 16 fractions, A−P, as described previously.23
Fraction D was separated by ODS and eluted in a step-gradient manner
with MeOH/H2O (5:95 to 100:0), to afford compound 1 (1.5 g).
Garcinol (1): yellow gum; [α]2D0 −160 (c 0.04, CHCl3); UV (MeOH)
λmax (log ε) 280 (3.47) nm; ECD (c 4.85 × 10−4 M, MeOH) λmax nm
(Δε) 198 (−27.99), 225 (+13.12), 269 (−21.29); IR (KBr) νmax 3396,
2969, 2923, 1727, 1639, 1602, 1523, 1442, 1375, 1290, 1193, 1116, 892,
777 cm−1; 1H NMR (600 MHz, CDCl3) δ 7.01−6.98 (m, 2H), 6.65 (d,
J = 8.2 Hz, 1H), 5.10 (m, 1H), 5.04 (d, J = 8.2 Hz, 1H), 4.92 (t, J = 7.0
Hz, 1H), 4.40 (d, J = 24.0 Hz, 2H), 2.77−2.71 (m, 2H), 2.59−2.56 (m,
1H), 2.35 (d, J = 14.0, 1H), 2.15−2.08 (m, 4H), 1.95−2.01 (m, 2H),
1.93−1.85 (m, 2H), 1.80 (s, 3H), 1.73 (s, 3H), 1.69 (s, 3H), 1.67 (s,
3H), 1.60 (s, 3H), 1.54 (s, 3H), 1.44−1.42 (m, 2H), 1.25 (s, 3H), 1.15
(s, 3H), 1.05 (m, 1H), 1.01 (s, 3H); HRESIMS m/z 603.3687 [M +
H]+ (calcd for C38H51O6, 603.3686).
ASSOCIATED CONTENT
■
sı
* Supporting Information
The Supporting Information is available free of charge at
HRESIMS, IR, ECD, NMR spectra, and X-ray crystallo-
graphic data of compounds 1 and 2 (PDF)
Single-crystal X-ray diffraction data for compound 1
Single-crystal X-ray diffraction data for compound 2
AUTHOR INFORMATION
■
Corresponding Authors
Hong-Xi Xu − Shuguang Hospital, Shanghai University of
Traditional Chinese Medicine, Shanghai 201203, People’s
Hong Zhang − School of Pharmacy, Shanghai University of
Traditional Chinese Medicine, Shanghai 201203, People’s
Republic of China; Phone: +86-21-51322066;
Crystal Data for 1. C40H53NO6 (M = 643.83 g/mol): monoclinic,
space group P21 (no. 4), a = 10.8272(4) Å, b = 9.0795(3) Å, c =
19.3623(7) Å, β = 103.0290(10)°, V = 1854.42(11) Å3, Z = 2, T = 173.0
K, μ(Cu Kα) = 0.607 mm−1, Dcalc = 1.153 g/cm3, 13 031 reflections
measured (4.684° ≤ 2θ ≤ 136.366°), 6546 unique (Rint = 0.0253, Rsigma
= 0.0339), which were used in all calculations. The final R1 was 0.0350
(I > 2σ(I)) and wR2 was 0.0943. Flack parameter = 0.14(7). Hooft =
0.14(7). Crystallographic data for 1 have been deposited at the
Cambridge Crystallographic Data Center (deposition number: CCDC
2032861).
Authors
Dan Zheng − School of Pharmacy, Shanghai University of
Traditional Chinese Medicine, Shanghai 201203, People’s
Republic of China
Jia-Ming Jiang − School of Pharmacy, Shanghai University of
Traditional Chinese Medicine, Shanghai 201203, People’s
Republic of China
Si-Min Chen − School of Pharmacy, Shanghai University of
Traditional Chinese Medicine, Shanghai 201203, People’s
Republic of China
Shi-Jie Wan − School of Pharmacy, Shanghai University of
Traditional Chinese Medicine, Shanghai 201203, People’s
Republic of China
Conversion of 1 to 2. A solution of 10 mg of 1 in 5 mL of toluene
and 30 μL of concentrated HCl was refluxed for 40 min. After cooling,
the reaction mixture was washed with H2O (3 × 5 mL) and evaporated
to dryness. Compound 2 (3.5 mg) was obtained as colorless prismatic
crystals from acetone/MeOH. The conversion can also be achieved
thermally by heating 1 (10 mg) at 200 °C for 5 min, from which 5 mg of
2 was obtained under the same recrystallization conditions.
Cambogin (2): colorless prismatic crystal; mp 238−239 °C; [α]D20
−132 (c 0.02, CHCl3); UV (MeOH) λmax (log ε) 234 (3.66), 279
(3.73) nm; ECD (c 6.31 × 10−4 M, MeOH) λmax nm (Δε) 228 (+8.18),
263 (−10.03), 343 (+3.35); IR (KBr) νmax 3461, 2971, 2925, 1720,
Han-Gui Ren − School of Pharmacy, Shanghai University of
Traditional Chinese Medicine, Shanghai 201203, People’s
Republic of China
1401
J. Nat. Prod. 2021, 84, 1397−1402